Drawing for TRANSFORM-MINER

USPTO serial 79333034

TRANSFORM-MINER

Reviewed by CopyMark Law Group

Reg. 7039194Status 700Registered
Filing date
Status date
Registration date
May 2, 2023
Examiner
MMEJE, OBIEZE GINIKANWA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRANSFORM-MINER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mari-Elise Paul

Mari-Elise Paul McBrayer PLLC500 West Jefferson St., Suite 2400Louisville, KY 40202United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for use in the fields of genetics, genomics, proteomics and biomedicine; downloadable electronic publications in the nature of pdfs, journals, and books in the fields of genetics, genomics, proteomics and biomedicine; electronic data processing apparatus for use in the fields of genetics, genomics, proteomics and biomedicineACTIVE—
016Printed matter, namely, newspapers, photographs, magazines, books, printed periodicals, newsletters, and brochures in the fields of genetics, genomics, proteomics and biomedicine; printed reports in the field of genetics, genomics, proteomics and biomedicine; printed journals in the fields of genetics, genomics, proteomics and biomedicine; printed instructional and teaching materials for use in the fields of genetics, genomics, proteomics and biomedicineACTIVE—
041Publication of texts, books, and journals in the fields of genetics, genomics, proteomics and biomedicine; educational services, namely, providing classes, seminars, workshops in the fields of genetic, genomics, proteomics and biomedicineACTIVE—
042Software design and development for use in the fields of genetics, genomics, proteomics and biomedicine; maintenance of computer software for use in the fields of genetics, genomics, proteomics and biomedicine; design and development of computer hardware for use in the fields of genetics, genomics, proteomics and biomedicine; computer programming services in the fields of genetics, genomics, proteomics and biomedicine; consultation services relating to computer software for use in the fields of genetics, genomics, proteomics and biomedicine; consultation services relating to the design and development of computer hardware for use in the fields of genetics, genomics, proteomics and biomedicine; scientific and technological services, namely scientific research, analysis, and testing in the fields of genetics, genomics, proteomics and biomedicine; scientific consultancy in the fields of genetics, genomics, proteomics and biomedicine; technological consultation in the technology fields of genetics, genomics, proteomics and biomedicine; design services in the fields of genetics, genomics, proteomics and biomedicine; design consultation in the fields of genetics, genomics, proteomics and biomedicine; Information technology consultancy and advisory in the technology fields of genetics, genomics, proteomics and biomedicine; providing technology information in the fields of genetics, genomics, proteomics and biomedicine; provision of scientific information in the fields of genetics, genomics, proteomics and biomedicineACTIVE—
044Medical services in the fields of genetics, genomics, proteomics and biomedicine; veterinary services in the fields of genetics, genomics, proteomics and biomedicine; provision of medical information relating to genetics, genomics, proteomics and biomedicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 8, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 8, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 8, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 27, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 28, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 8, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 8, 2023FIMPFINAL DISPOSITION PROCESSED—
Aug 2, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 2, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 2, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 25, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 25, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 25, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 8, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jan 8, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 8, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 8, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 29, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 3, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 3, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 29, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 28, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2022DOCKASSIGNED TO EXAMINER—
Feb 15, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance